Monocrotaline-Induced Pulmonary Arterial Hypertension and Bosentan Treatment in Rats: Focus on Plasma and Erythrocyte Parameters
Authors:
- Tomas JasenovecTJTomas Jasenovec
- Dominika RadosinskaDRDominika Radosinska
- Marta KollarovaMKMarta Kollarova
- Norbert VrbjarNVNorbert Vrbjar
- Peter BalisPBPeter Balis
- Simona TrubacovaSTSimona Trubacova
- Ludovit PaulisLPLudovit Paulis
- Lubomira TothovaLTLubomira Tothova
- Ivana ShawkatovaISIvana Shawkatova
- Jana RadosinskaJRJana Radosinska
Open Access
- 5 October 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (10) , 1227
Abstract
The objective of our study was to contribute to the characterization of monocrotaline-induced pulmonary arterial hypertension (PAH) in a rat model, with emphasis on the renin–angiotensin–aldosterone system, parameters of oxidative stress, the activity of matrix metalloproteinases, and erythrocyte parameters. Moreover, we aimed to analyze the effects of bosentan. Experiments were performed on 12-week-old male Wistar rats randomly assigned to 3 groups: control, monocrotaline-treated (60 mg/kg), and monocrotaline combined with bosentan (300 mg/kg/day). Our study confirmed the well-known effects of monocrotaline administration on lungs and the right ventricle, as well as pulmonary arterial pressure. In addition, we observed activation of the alternative pathway of the renin–angiotensin system, namely an increase in angiotensin (Ang) 1–7 and Ang 1-5 together with an increase in Ang I, but without any change in Ang II level, and downregulation of aldosterone 4 weeks after monocrotaline administration. For the first time, modifications of erythrocyte Na,K-ATPase enzyme kinetics were demonstrated as well. Our observations do not support data obtained in PAH patients showing an increase in Ang II levels, increase in oxidative stress, and deterioration in RBC deformability. Although bosentan primarily targets the vascular smooth muscle, our study confirmed its antioxidant effect. The obtained data suggest that besides the known action of bosentan, it decreases heart rate and increases erythrocyte deformability, and hence could have a beneficial hemodynamic effect in the PAH condition.Keywords
Funding Information
- Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky (VEGA 1/0193/21, APVV-18-0287, FFG 872313)
- Agentúra na Podporu Výskumu a Vývoja (VEGA 1/0193/21, APVV-18-0287, FFG 872313)
- Österreichische Forschungsförderungsgesellschaft (VEGA 1/0193/21, APVV-18-0287, FFG 872313)
This publication has 66 references indexed in Scilit:
- Diaphragm Atrophy and Contractile Dysfunction in a Murine Model of Pulmonary HypertensionPLOS ONE, 2013
- Pulmonary Hypertension in Lambs Transfused with Stored Blood Is Prevented by Breathing Nitric OxideAnesthesiology, 2012
- Gene Expressions of Nitric Oxide Synthase and Matrix Metalloproteinase-2 in Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan TreatmentKorean Circulation Journal, 2011
- Downregulation of oxytocin receptors in right ventricle of rats with monocrotaline‐induced pulmonary hypertensionActa Physiologica, 2010
- Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in ratsEuropean Respiratory Journal, 2009
- Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell diseaseJournal of Clinical Investigation, 2008
- Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2005
- Right ventricular hypertrophy in monocrotaline pyrrole treated ratsExperimental and Molecular Pathology, 1974